FDA finally approves Amylin's once-a-week diabetes injection

Share this article:

The third time was the charm for Amylin Pharmaceuticals' once-a-week diabetes injection drug. Bydureon was approved Friday, following two prior rejections. Amylin executives say the new drug's convenient regimen will give it a competitive advantage in the marketplace. Diabetes affects more than 25 million people in the U.S., including many nursing facility residents.


Share this article:

More in Products

Stents safe for stroke prevention, study says

Placing a stent to keep a neck artery open is as effective as invasive neck surgery for long-term prevention of strokes, according to results from a European trial.

Honeywell Introduces remote patient monitor

Honeywell Introduces remote patient monitor

Honeywell has launched the HomMed Genesis DM™ v4.15, a new version of the remote patient monitor with new peripheral devices.

NKF launches interactive nutrition portal

NKF launches interactive nutrition portal

The National Kidney Foundation has debuted My Food Coach, an interactive nutrition panel meant to allow people to easily manage nutritional requirements.